Kotak Equities highlights that Lupin has a bunch of products lined up, which will ensure a limited earnings dip in FY2027E after a strong F...

Macquarie maintained an underperform rating on Zomato with a target price of Rs 76. The company has seen steady margin improvements and str...

Lupin's focus on the US portfolio is to increase dollar sales to above $200 million from the earlier range of $170-190 million. Lupin recen...

Morgan Stanley maintained an overweight rating on Aarti Industries with a target price of Rs 575. Agrochemicals make up one-third of Aarti'...

Delhivery can sustain strong 18-20% revenue CAGR for a long period of time. Over the medium term, the brokerage firm sees adjusted EBIT mar...

Lupin witnessed a fall of over 4% to Rs 838.1 in intra-day trade on BSE after brokerages such as Jefferies, Kotak, and Bernstein maintained...

Jefferies upgraded Shriram Finance to "buy" and retained a "buy" rating on L&T while Antique initiated a "buy" on Paradeep Phosphates. Kota...

Jefferies maintained an underperform rating on Hindustan Petroleum Corporation Limited (HPCL) citing weak marketing and transitory refining...

A team of analysts from global brokerage firm Jefferies has raised the FY23 earnings estimates for 47% of 147 companies under its coverage ...

Of the 44 analysts, 18 of them have a 'sell' rating while 15 remain neutral. On aggregate, analysts slashed consensus price targets by 4.35...

Lupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 31616.79 Crore) operating in Pharmaceuticals s...

Lupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 36549.22 Crore) operating in Pharmaceuticals s...